Showing results (211-220 of 397) with videos related to
Sort By:
Pageof 40
The New England Journal of Medicine|April 5, 2016
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart FailureJohn J V McMurray, Henry Krum, William T Abraham, et al.Circulation|April 2, 2008
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysisScott D Solomon, Janet Wittes, Peter V Finn, et al.Circulation. Cardiovascular Quality and Outcomes|August 1, 2013
Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF)Jonathan G Howlett, Justin A Ezekowitz, Mohua Podder, et al.Ugeskrift for Laeger|February 16, 2006
[Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication]Ida Gustafsson, Klas Malmberg, Lars Rydén, et al.European Journal of Heart Failure|September 6, 2017
'heartfailurematters.org', an educational website for patients and carers from the Heart Failure Association of the European Society of Cardiology: objectives, use and future directionsKim P Wagenaar, Frans H Rutten, Leonie Klompstra, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 22, 2014
European cardiac resynchronization therapy survey II: rationale and designKenneth Dickstein, Camilla Normand, Stefan D Anker, et al.European Journal of Heart Failure|January 17, 2020
Predictors of sudden cardiac death in high-risk patients following a myocardial infarctionKieran F Docherty, João Pedro Ferreira, Abhinav Sharma, et al.The Journal of Pediatrics|May 2, 2006
Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension studyPaul Harmatz, Roberto Giugliani, Ida Schwartz, et al.Journal of Hypertension|April 19, 2005
Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical regionHenry R Black, William J Elliott, Gregory Grandits, et al.Hypertension (Dallas, Tex. : 1979)|February 24, 2001
Baseline Characteristics and Early Blood Pressure Control in the CONVINCE TrialHenry R. Black, William J. Elliott, James D. Neaton, et al.Pageof 40